What is pharmacogenomics?

• A. The study of drug prices
• B. The study of how genetics affect drug response
• C. The study of drug manufacturing processes
• D. The application of chemistry in drug formulation

Answer: (B)

Pharmacogenomics is defined as the study of how genetics impact an individual's response to medications. This field merges pharmacology, which is the study of drugs and their effects on the body, with genomics, the study of genes and their functions. The aim of pharmacogenomics is to understand how variations in DNA can influence drug effectiveness and the likelihood of adverse effects, ultimately guiding personalized medicine. By tailoring medication regimens based on a person's genetic makeup, healthcare providers can improve therapeutic outcomes and reduce the risk of side effects.

The other options, while related to pharmaceutical sciences, do not capture the essence of pharmacogenomics. For instance, drug prices pertain to the economic aspects of pharmaceuticals rather than the biological and genetic factors influencing drug response. Drug manufacturing processes involve the techniques and procedures used to produce medications, while the application of chemistry in drug formulation focuses on the chemical composition and synthesis of drugs, not on the genetic factors that affect how individuals respond to them.